Sign inGet started

MATHEWS CHARLES

Insider CIK 1190315 · LPTN Director · AVNR Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LPTN LPATH, INC M Exercise deriv2016-03-092016-03-163,485— $00SEC↗
LPTN LPATH, INC M Exercise2016-03-092016-03-163,485— $019,916SEC↗
LPTN LPATH, INC A Award deriv2016-02-162016-02-1825,000— $025,000SEC↗
LPTN LPATH, INC M Exercise deriv2015-04-222015-04-235,715— $00SEC↗
LPTN LPATH, INC M Exercise2015-04-222015-04-235,715— $016,431SEC↗
LPTN LPATH, INC A Award deriv2015-02-102015-02-1216,667— $00SEC↗
LPTN LPATH, INC A Award deriv2014-02-102014-02-1215,000— $015,000SEC↗
LPTN LPATH, INC M Exercise deriv2014-02-102014-02-122,858— $00SEC↗
LPTN LPATH, INC M Exercise2014-02-102014-02-122,858— $010,716SEC↗
LPTN LPATH, INC A Award deriv2013-01-292013-01-316,012— $06,012SEC↗
LPTN LPATH, INC P Buy2012-12-192012-12-205,000$4.98 $24.9K7,858SEC↗
LPTN LPATH, INC M Exercise deriv2012-11-202012-11-212,858— $00SEC↗
LPTN LPATH, INC M Exercise2012-11-202012-11-212,858— $02,858SEC↗
LPTN LPATH, INC A Award deriv2012-03-142012-03-2740,000— $040,000SEC↗
AVNR AVANIR PHARMACEUTICALS, IN P Buy2012-03-062012-03-075,000$2.69 $13.4K5,000SEC↗
AVNR AVANIR PHARMACEUTICALS, IN A Award2012-02-162012-02-1730,000— $0270,094SEC↗